Medicaid steering toward better plans—but who defines 'better'?

What it does

This bill requires states to evaluate Medicaid managed care companies based on their performance—measuring costs, hospital readmissions, emergency visits, and patient satisfaction—and use those scores to steer new Medicaid enrollees toward better-performing plans. States must publish annual reports showing how many people are steered this way and estimate any savings. The rule takes effect January 1, 2028.

Why we flagged it

The bill's core function is to create a performance-scoring system for Medicaid managed care plans and use those scores to influence enrollment. It is a regulatory/administrative reform, not a funding or commemorative measure.

What the text implies

• States gain discretion to define 'performance'—measures like cost and readmission are specified, but states choose which ones to weight and how. This could create variation in which plans are favored across states.
• Managed care entities with lower cost scores may see enrollment decline, potentially reducing their revenue and market share. Plans serving sicker or more complex populations may score lower on cost metrics even if quality is high, creating perverse incentives.
• The bill does not specify how states must handle tie-breaking or how aggressively to steer enrollees, leaving room for implementation variation and potential gaming of performance metrics.
• Public reporting requirement may increase transparency but also creates competitive pressure that could incentivize plans to avoid high-cost patients or underinvest in complex care.

Who it affects

Medicaid beneficiaries gain transparency and choice steering toward higher-quality, lower-cost plans. States gain a tool to reduce unnecessary hospitalizations and emergency visits, potentially lowering costs and improving care. The mechanism is performance-based, not arbitrary, and requires public reporting.

Who stands to gain

• Medicaid managed care plans with strong cost and quality performance
• States (via reduced Medicaid expenditures)
• Costco (mapped stock reference—likely due to healthcare cost/value angle, though not directly named

Named in the bill

Medicaid, Social Security Act Section 1932, Managed Care Entities, States, COST (Costco Wholesale Corp.)

Where it stands

1 cosponsor: 1 Republicans.

• Jun 18, 2026 — Introduced · Congress.gov: “Introduced in House”
• Jun 18, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $50,000 in lobbying spend. A filing names 1 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Craig Goldman, the sponsor, reported $682,667 in PAC receipts in the 2026 cycle.

• Solventum Health Information Systems, Inc. — $50,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.